Description
[4-(4-Aminophenoxy)(2-pyridyl)]-N-methylcarboxamide is an intermediate of Sorafenib, which is a kinase inhibitor drug used for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Synonyms
4-(4-Aminophenoxy)-N-methylpicolinamide; 4-[[2-(N-Methylcarbamoyl)-4-pyridyl]oxy]aniline; 4-[(4-aminomethyl)phenoxy]-2-pyridine carbonic acid methylamide; Sorafenib Imp -1; Sorafenib Related Compound 23
IUPAC Name
4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide
Molecular Formula
C13H13N3O2
Canonical SMILES
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)N
InChI
InChI=1S/C13H13N3O2/c1-15-13(17)12-8-11(6-7-16-12)18-10-4-2-9(14)3-5-10/h2-8H,14H2,1H3,(H,15,17)
InChIKey
RXZZBPYPZLAEFC-UHFFFAOYSA-N
Boiling Point
476.8±40.0°C (Predicted)
Density
1.241±0.06 g/cm3 (Predicted)
Solubility
Soluble in DMSO (Slightly), Methanol (Slightly)
Appearance
Light brown to brown solid